Abstract

BackgroundEven though malaria incidence has decreased substantially in Guatemala since 2000, Guatemala remains one of the countries with the highest malaria transmission in Mesoamerica. Guatemala is committed to eliminating malaria as part of the initiative ‘Elimination of Malaria in Mesoamerica and the Island of Hispaniola’ (EMMIE); however, it is still in the control phase. During the past decade, the government strengthened malaria control activities including mass distribution of long-lasting insecticide-impregnated bed nets, early diagnosis and prompt treatment. This study aimed to determine the prevalence of malaria, including gametocytes, in three areas of Guatemala using active case detection (ACD) and quantitative polymerase chain reaction (qPCR).MethodsCross-sectional surveys were conducted in three departments with varying transmission intensities: Escuintla, Alta Verapaz and Zacapa. Blood samples from 706 volunteers were screened for malaria using microscopy and qPCR which was also used to determine the prevalence of gametocytes among infected individuals. Results were collected and analysed using REDCap and R Project, respectively.ResultsMalaria was diagnosed by microscopy in only 2.8 % (4/141) of the volunteers from Escuintla. By contrast, qPCR detected a prevalence of 7.1 % (10/141) in the same volunteers, 8.4 % (36/429) in Alta Verapaz, and 5.9 % (8/136) in Zacapa. Overall, 7.6 % (54/706) of the screened individuals were positive, with an average parasitaemia level of 40.2 parasites/μL (range 1–1133 parasites/μL) and 27.8 % carried mature gametocytes. Fifty-seven percent (31/54) of qPCR positive volunteers were asymptomatic and out of the 42.6 % of symptomatic individuals, only one had a positive microscopy result.ConclusionsThis study found a considerable number of asymptomatic P. vivax infections that were mostly submicroscopic, of which, approximately one-quarter harboured mature gametocytes. This pattern is likely to contribute to maintaining transmission across the region. Robust surveillance systems, molecular diagnostic tests and tailored malaria detection activities for each endemic site may prove to be imperative in accelerating malaria elimination in Guatemala and possibly across all of Mesoamerica.Electronic supplementary materialThe online version of this article (doi:10.1186/s12936-016-1500-6) contains supplementary material, which is available to authorized users.

Highlights

  • Even though malaria incidence has decreased substantially in Guatemala since 2000, Guatemala remains one of the countries with the highest malaria transmission in Mesoamerica

  • Prevalence of Plasmodium vivax infections All detected malaria infections were caused by P. vivax

  • The overall prevalence of malaria diagnosed by quantitative polymerase chain reaction (qPCR) was 7.6 % (54/706, 95 % CI: 5.8–9.9), of which 7.4 % (4/54) were positive by Thick blood smears (TBSs). qPCR positive individuals were distributed as follows: 7.1 % (10/141, CI: 3.6–13.0) in Escuintla, 8.4 % (36/429, CI: 2.8–11.6) in Alta Verapaz and 5.9 % (8/136, CI: 6.0–11.5) in Zacapa (Fig. 4a)

Read more

Summary

Introduction

Even though malaria incidence has decreased substantially in Guatemala since 2000, Guatemala remains one of the countries with the highest malaria transmission in Mesoamerica. Malaria still represents a major global public health issue despite the significant reduction of cases during the past. Seven countries in the Americas are in the elimination phase; Argentina, Belize, Costa Rica, Ecuador, El Salvador, Mexico and Paraguay [1]. Despite this significant regional reduction in malaria burden, which was most remarkable in the Mesoamerican region, several countries including Panama, Nicaragua, Honduras and Guatemala still maintain significant transmission [1]. Many challenges remain and factors such as the tropical and humid climate, poverty, lack of education and poor diagnostics and adherence to treatment all contribute to the maintenance of malaria in the country

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call